NCT00558272 2013-05-27Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseAstraZenecaPhase 2 Completed139 enrolled 23 charts
NCT00475956 2010-04-15Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed40 enrolled